open-label, multicentre, two-arm phase III comparative study assessing
the role of mediastinal radiotherapy after Rituximab containing
chemotherapy regimens to patients with newly diagnosed Primary
Mediastinal Large B-Cell Lymphoma (PMLBCL)
Before any patient registration, PET centre formal accreditation must undergo.
In order to receive the login data, please send an e-mail to the IELSG Operation Office with the details of the Institution, the name of the PET physician responsible and his e-mail address.
STUDY REGISTRATION AND CRFs
Study registration and CRFs have to be completed on line connecting the OpenClinica platform. The login data are provided by IELSG.
For information please contact the IELSG operation office
phone ++41 91 811 9040 - 811 9060 - 811 9041
fax ++41 91 811 9182